Dr Wasif has been recognized as an internationally renowned expert and Key Opinion Leader (KOL) in
the fields of Gastrointestinal (GI) cancers, Experimental Therapeutics and Pharmacogenetics, an
exemplary clinician. He is a clinical and translational cancer researcher at Tufts Medical Center
(MC) where he is a Professor of Medicine and serve as the Director of the GI Cancers Program
and Program Leader of the Experimental Therapeutics Program at the Tufts Cancer Center, Tufts
Medical Center, Boston. In the former role,he is responsible for the overall development and
management of the clinical as well as research aspects of the program including clinical trials,
standardization of treatment algorithms, multidisciplinary tumor board, collaboration among
different modalities and mentorship for fellows interested in the subspecialty. In the latter role, he is responsible for the oversight and coordination for phase I studies. His administrative skills were first fostered at the Yale Cancer Center when he was assigned the
role of Director of the GI Oncology disease team. In the words of Dr. Edward Chu, Chief of
Medical Oncology and Deputy Director of Yale Cancer Center, “ During his six years at Yale,
Wasif did a spectacular job in conducing novel clinical trials for patients with advanced
pancreatic cancer and metastatic colorectal cancer.